Cargando…
Pathophysiology of Diabetic Dyslipidemia
Accumulating clinical evidence has suggested serum triglyceride (TG) is a leading predictor of atherosclerotic cardiovascular disease, comparable to low-density lipoprotein (LDL)-cholesterol (C) in populations with type 2 diabetes, which exceeds the predictive power of hemoglobinA1c. Atherogenic dys...
Autor principal: | Hirano, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143775/ https://www.ncbi.nlm.nih.gov/pubmed/29998913 http://dx.doi.org/10.5551/jat.RV17023 |
Ejemplares similares
-
Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016) -
Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment
por: Higgins, Victoria, et al.
Publicado: (2017) -
Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature
por: Esfarjani, Shahla V., et al.
Publicado: (2022) -
Diabetes and dyslipidemia: characterizing lipoprotein metabolism
por: Tomkin, GH, et al.
Publicado: (2017) -
Treatment of dyslipidemia in patients with type 2 diabetes
por: Vijayaraghavan, Krishnaswami
Publicado: (2010)